Application of berberine to preparing drug for preventing and treating familial adenomatous polyp

A technology of berberine and family, applied in the field of application of berberine in the preparation of drugs for the prevention and treatment of familial adenomatous polyps, can solve problems such as unclear molecular mechanism, and achieve good prevention and treatment effect

Inactive Publication Date: 2011-05-18
GENERAL HOSPITAL OF TIANJIN MEDICAL UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, scholars at home and abroad have also found that berberine ha

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of berberine to preparing drug for preventing and treating familial adenomatous polyp
  • Application of berberine to preparing drug for preventing and treating familial adenomatous polyp
  • Application of berberine to preparing drug for preventing and treating familial adenomatous polyp

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0012] Berberine inhibits the proliferation of FAP cell lines: In recent years, the dysregulation of EGFR signaling pathway is closely related to the occurrence and carcinogenesis of FAP polyps, and it is an important target for tumor prevention and treatment. Colonic polyps and tumor epithelium highly express EGFR, which stimulates its autophosphorylation through dimerization after being activated by ligands such as EGF, leading to cascade amplification and activation of downstream signaling pathways. The classic EGFR pathways mainly include: ① Mitogen-activated protein kinase pathway (Ras / Raf / MEK / ERK / MAPK pathway): by activating extracellular signal-regulated protein kinase 1 (ERK1), ERK2 and JNK / p38-MAPK, etc. , phosphorylate cytoplasmic proteins, and also enter the nucleus to phosphorylate transcription factors, activate nuclear AP-1, and mainly mediate cell proliferation and differentiation; ② Phosphatidylinositol 3-kinase (PI3K) pathway: the product of PI3K, PIP3, regulat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to novel application of berberine, in particular to application of the berberine to preparing a drug for preventing and treating familial adenomatous polyp (FAP). The FAP is an autosomal dominant hereditary disease which is characterized by multiple adenomatous polyps in the digestive tract, mainly comprises CFAP (Classical Familial Adenomatous Polyp) and AFAP (Attenuated Familial Adenomatous Polyp) and is not rare in clinic; and early intervention is significant. In the invention, the applied berberine can bring inhibitory action to the cell growth of colon cancer cells and FAP cell line (IMCE), wherein the mechanism includes inhibiting cell proliferation, promoting apoptosis, down regulating expression of COX-2 and AP-1, inhibiting synthesis of PGE2 (Prostaglandin E2) and activation of EGFR (Epidermal Growth Factor Receptor) and Akt and brings out well effect when applied to FAP patients in a long term. The invention provides a novel safe, effective, and economic method for preventing and treating the FAP.

Description

【Technical field】 [0001] The invention relates to a new application of berberine, in particular to the application of berberine in the preparation of drugs for preventing and treating familial adenomatous polyps. 【Background technique】 [0002] Familial adenomatous polyposis (FAP) is an autosomal dominant genetic disease characterized by multiple adenomatous polyps in the digestive tract, and its pathogenesis is mainly related to Apc mutation. Due to the special genetic background of FAP, it has become one of the hotspots in the field of colorectal disease research. At present, it is considered that FAP mainly includes classical FAP (classical FAP, CFAP) and attenuated FAP (attenuated FAP, AFAP). CFAP is commonly known as FAP. If the number of polyps exceeds 100, it often has an obvious family history and the age of canceration is relatively young; if the number of AFAP polyps is less than 100, it is often combined with upper gastrointestinal polyps, and its canceration is ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/4375A61P1/00
Inventor 王邦茂方维丽鄢芳李姝曹海龙王涛姜葵张庆瑜杨玉龙
Owner GENERAL HOSPITAL OF TIANJIN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap